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Abstract 
Some degree of cognitive impairment appears frequently in Parkinson´s disease (PD) 
patients, even at the onset of the disease. However, due to the heterogeneity of the 
patients and the lack of standardized assessment batteries, it remains unclear which 
capacities are primarily affected by this disease. Fifty PD patients were assessed with 15 
tests including executive functions, attention, temporal and spatial orientation, memory, 
and language tasks. Their results were compared to those of 42 age- and education-
matched healthy seniors. Semantic fluency, along with visual search appeared to be the 
most discriminant tasks, followed by temporal orientation and face naming, as well as 
action naming and immediate recall. PD patients studied showed an impairment of 
frontal- to posterior-dependent capacities. Executive functions, attention and recall tasks 
appeared to be significantly impaired in the patients. Nevertheless, significantly poor 
scores in tasks like action and face naming, as well as semantic fluency, also reveal a 
mainly semantic deficit. 
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Introduction 
Though there is some heterogeneity in previous data, it is agreed that some 
degree of cognitive impairment is present in a considerable number of patients suffering 
from Parkinson’s disease (PD) 1-6. Thus, whereas early studies based on DSM-III 
criteria had found that 14% of PD patients present dementia1, more recent work 
estimates prevalence rates around 30% 2-6. Furthermore, when fine-grained 
neuropsychological and cognitive measures are used, a certain level of cognitive 
impairment can be identified even in some PD patients who cannot be diagnosed with 
dementia yet 2, 6, 7. The diagnostic label Mild Cognitive Impairment (MCI)8, borrowed 
from the domain of Alzheimer’s disease (AD), has been applied to these patients with 
the intention of describing an intermediate state between preserved cognitive capacity 
and fully-established dementia in PD2, 6. Given that MCI is considered to be a precursor 
of dementia6 and one of the best predictors of its appearance9, 10, it is imperative to 
conduct a formal neuropsychological examination of PD patients, in order to ascertain 
their degree and pattern of cognitive preservation over the course of the disease. 
However, given that normative data for extensively used scales, like MMSE or the 
Mattis Dementia Rating Scale, is incomplete in PD populations, along with the fact that 
the cognitive profile in PD with dementia differs significantly from that in AD 11, 
specific tools must be designed to assess the cognitive decline in PD. Several specific 
tests have reported their usefulness in PD but the lack of concordance 12 and absence of 
studies comparing the performance of PD without dementia patients with controls lead 
to question their validity.  
The most common deficits described are related to executive functions 3, 4, 6, 13-15, 
although visuospatial 14, 16, 17, attentional 14, 18, memory 3, 4, 6, 19, 20, and language 15, 21 
impairments have also been observed in this kind of patients. Some of these disorders 
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have been detected even in the early stages of the disease 22, 23, while others appear in 
later stages. In an attempt to put order to the cognitive heterogeneity present in PD 
patients, signs of cognitive impairment have been proposed to cluster into two main 
groups 24. Thus, whereas some of the PD patients present reduced attention and 
executive capacities, others show a pattern of impairment that is primarily characterized 
by memory loss. These two cognitive impairment profiles would be the result of frontal 
lobe- and temporal lobe-dependent pathology respectively 24. However, it has also been 
suggested that the executive deficit is the primary cause of the other symptoms 
including the language and memory impairments 17, 19. 
The identification of preclinical dementia in PD patients provides an opportunity 
to understand cognitive decline in PD and is, thus, crucial for accurate management and 
prompt treatment. Selecting the cognitive functions to be included in an assessment 
battery is the first step to build a rational screening test. Obviously, this selection should 
include the ones that have been affected since the beginning of the disease. Moreover, it 
is important to assess a variety of cognitive abilities that cover a full range of anterior to 
posterior-dependent functions, in order to disentangle the contribution of executive 
function to the expressed deficits. 
 In this study we conducted a systematic evaluation of a range of cognitive 
functions including orientation, attention, executive function, memory and language. In 
some cases, several tasks were designed for each capacity in order to be able to establish 
fine-grained conclusions regarding the exact origin of the deficit. PD patients without 
dementia were compared to controls of similar demographic characteristics with the aim 
of detecting cognitive deficits before the dementia stage.  
 
Materials and methods 
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Participants 
A group of 50 PD patients and a group of 42 healthy seniors took part in the 
experiment. The two groups of participants were matched on age and years of education, 
but PD patients presented significantly lower (t(80.54)=-2.76; p=.007) average MiniMental 
State Evaluation (MMSE) scores. Informed consent was obtained from all the participants 
or their relatives. PD patients had been diagnosed according to the UK Parkinson’s Disease 
Brain Bank criteria 25 prior to their participation in the experiment. Only native Spanish 
speakers with no history of alcohol abuse, or neurological or psychiatric disorders other 
than PD were included in the study. The criteria by the Movement Disorder Society 13, 26 
were used to discard dementia. A summary of participant’s characteristics is provided in 
table 1. 
 
Table 1 here 
 
Stimuli and Procedure 
Participants were tested with a battery consisting of 15 tasks. The tests were aimed to 
study those cognitive abilities that are known to be impaired in PD patients, like executive 
function and attention, but also other capacities like temporal and spatial orientation; 
semantic and episodic memory; and language production and comprehension. The tasks 
were: 
- Visual search: The participant must mark the number “3” every time it appears on a 12 
x 20 grid of the numbers 1 through 9. 
- Odd-one-out: Groups of four photographs are presented to the participant, who is 
asked to indicate which of them is different from the others. Three different criteria are 
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used: category (e.g., three apples and a pear), color (e.g., three yellow flowers and one red 
flower) and number (e.g., three single gloves and a pair of gloves). 
- Temporal Orientation: The participant is presented with five questions regarding 
placement in time (e.g., What day of the week is it? What year is it?). 
- Spatial Orientation: The participant is asked to answer five questions about spatial 
location (e.g., What city are we in? What street do you live on?). 
- Immediate recall: The participant is asked five questions about an imaginary friend 
(e.g., What’s my friend’s name? How old is he?) that is previously described to him (My 
friend’s name is Arthur, he is 46 years old, …). 
- Delayed recall: The participant is asked the same questions about the imaginary friend 
several minutes after the immediate recall test. 
- Semantic fluency: For 60 seconds, the participant is asked to name as many fruits as 
he or she can without repeating any.  
- Semantic association: The participant is asked to choose which of two drawings 
presented at the bottom of a page (e.g., a hammer and a padlock) is related to the one 
presented at the top (e.g., a key). 
- Object naming: Ten color drawings of objects are presented, half of them living things 
and half inanimate objects, for the participant to name. 
- Action naming: Ten color drawings of actions are presented for the participant to 
name. 
- Famous faces naming: The participant has to name ten photographs of famous people 
presented one by one. 
- Definition–word pairing: The participant must show which of the four presented 
words (e.g., vice, insult, swindle, prayer) corresponds to a given definition (e.g., deception 
with intent to profit). 
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- Synonymy: A word (e.g., plea) is presented at the top and another three (e.g., prayer, 
request, fervor) appear at the bottom of a sheet. The participant must indicate which of 
these three words is synonymous with the word at the top.  
- Phonological fluency: For 60 seconds, the participant must name as many words as he 
or she can that begin with the letter “f” and are not proper nouns. 
- Pseudoword repetition: The experimenter articulates ten pseudowords, each with three 
or four syllables, one by one for the participant to repeat. One point is awarded for each 
“correctly pronounced” pseudoword. 
 
Each participant was run through the experimental battery individually in two sessions 
scheduled two or three days apart. 
 
Results 
Table 2 presents averages and range of the scores of the two groups in the all the tasks 
and a summary of the results of the different analyses performed. The control group 
obtained higher scores than the PD groups on all of the tasks. A MANCOVA analysis 
conducted with group as an independent variable, the scores on the 16 tasks as dependent 
variables, and age of the participants as a covariable, yielded significant results [Pillai’s 
trace: V=0.367, F(15,69) = 2.663, p =.003].  
 
Table 2 here 
 
The age of the seniors appeared to be significantly related to their results in all the tasks 
(ps<.05) except for temporal orientation [F(1,83)=2.025, p=.158]. Between-subjects tests 
showed significant group differences on seven of the tasks including temporal orientation, 
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visual search, immediate recall, semantic fluency, face and action naming, as well as odd-
one-out. Differences between the scores of the Parkinson and control groups in the delayed 
recall task approached the significance threshold. In order to ascertain which of the tasks 
would continue discriminating between healthy seniors and PD patients when global 
cognitive function is controlled, a second analysis was conducted introducing MMSE 
scores as a covariable [Pillai’s trace: V=0.336, F(16,69) = 2.307, p =.008]. General 
cognitive decline appeared to be significantly related to scores in all the tasks (ps<.05) but 
visual search [F(1,88)=0.499, p=.482] and semantic association [F(1,88)=1.067, p=.158]. 
When this variable was controlled significant differences appeared only between the 
participants’ scores in temporal orientation [F(1,88)=4.545, p=.036], visual search 
[F(1,88)=11.099, p=.001] and semantic fluency [F(1,88)=5.495, p=.021].  
MANCOVA analyses were followed up by a discriminant analysis (see table 2) 
conducted with diagnosis as the dependent variable and the different tasks as independent 
variables. The test battery appeared to correctly distinguish 80.4% of the cases, with 
positive and negative predictive values of 76% and 86% respectively. ROC curves were 
also computed for each of the comparisons, yielding the area under the curve values also 
reported in table 2. Semantic fluency, along with visual search appeared to be the most 
discriminant tasks, followed by temporal orientation, face naming, as well as action naming 
and immediate recall. 
Furthermore, in order to provide a qualitative description of the impairment profiles of 
PD patients, a classification of their cognitive deficits was attempted. The patient sample 
was divided according to an established subclassification of MCI27 on the basis of their 
scores in the different tests. Whereas 20% of the patients appeared to present normal 
cognitive abilities, 32% of them were classified as amnestic MCI. The remaining patients 
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were considered either single non–memory-domain MCI (8%), or multiple-domain MCI 
(40%). 
 
Discussion 
In order to explore the profile of cognitive impairment in PD, a group of 50 non-
demented PD patients was assessed with a neuropsychological battery including memory, 
language, attention, orientation and executive function tasks. In line with previous results in 
the literature 3, 4, 6, 13-15 the presence of an executive function deficit in PD patients was 
confirmed in the sample studied here, as significant differences appeared between the 
scores of the PD and control groups in the odd-one-out test. Yet again, according to 
previous studies 3, 14, 18 PD patients presented an attention deficit that became apparent in 
their poor scores in the visual search task. Temporal orientation also appeared to be 
impaired in the PD group, with patients scoring significantly lower than healthy controls. 
Spatial orientation, however, was preserved in PD patients, who obtained scores similarly 
high to those of the control group. Visual search, odd-one-out and temporal orientation 
turned out to be amongst the four most discriminant tasks in our study. Furthermore, 
differences between the groups’ scores in temporal orientation and visual search appeared 
to be significant even when global cognitive impairment was controlled entering MMSE 
scores as a covariable in the analysis. Generally, this pattern of results is congruent with the 
well established idea 17, 19 that PD patients present a deficit in frontal lobe-dependent 
capacities. 
Concerning language, oral production difficulties can be ruled out in the PD group, as 
no significant differences appeared between their scores and those of control participants 
either in the phonological fluency or in the pseudoword repetition tasks. Reading 
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comprehension also appeared to be preserved in the patient group, with scores comparable 
to those of healthy seniors in both the synonymy and definition-word pairing tasks. 
The episodic memory of PD patients has previously been compared to that of patients 
suffering from AD. Immediate recall abilities of PD patients have been shown to be similar 
to those of AD patients 14 but better preserved in the case of delayed recall 28, 29. 
Accordingly, PD patients in our study produced significantly less correct responses than 
healthy seniors in the immediate recall task, although differences disappeared in the delayed 
recall test. Due to an alleged preservation of  recognition abilities of PD patients30, 31, their 
episodic memory impairments have been ascribed to retrieval deficits secondary to a 
general executive impairment 17. However there is compelling evidence that PD patients do 
suffer from a recognition deficit32, so coding difficulties cannot be ruled out as a possible 
cause of the episodic memory impairment of these patients.   
With regards to semantic memory, significant differences appeared in the semantic 
fluency task, suggesting a relative impairment of this capacity that, nevertheless, was not 
apparent in the semantic association task. This was probably due to a ceiling effect, as both 
groups obtained scores close to the maximum in the task. Semantic fluency is agreed to be 
one of the most sensitive task to detect cognitive impairment in PD patients 15, 17, 19. This is 
confirmed in our study, in which semantic fluency together with the visual search task 
obtained the greatest area under the ROC curve values. Similarly to what happens in the 
case of recall tasks, even though semantic fluency deficits have repeatedly been reported in 
previous studies 15, 19, it has been suggested that, rather than having a purely semantic 
origin, the poor scores obtained by PD samples in this task reveal a deficit of executive 
functions 14, 19. This assumption usually relies in the presence of deficits in the phonological 
fluency task, that is very similar to semantic fluency but with no semantic component 17. 
However, there is also evidence that PD patients are more impaired on tests of semantic 
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than phonemic fluency 15, 33. As no significant differences appeared between the scores of 
the PD and control groups in the phonological fluency task in our study, we are inclined to 
suggest that there is indeed a memory component in the semantic fluency deficit present in 
patients suffering from PD. Moreover, there is increasing evidence that the pattern of 
atrophy present in PD extends to medial temporal regions34, 35, what would explain the 
appearance of a memory-specific impairment.   
Special attention should be paid to the three naming tasks that allow us to assess 
different aspects of the semantic memory of the patients. No significant differences 
appeared between the scores of the PD and control groups in the object naming task. 
Nevertheless action and face knowledge turned out to be significantly impaired in PD 
patients, making face and action naming appear amongst the most discriminant tasks. 
Previous studies had noted the appearance of a relative impairment of action knowledge in 
PD participants 36, 37. This action-verb deficit has been taken as evidence of the crucial role 
of movement-related neural structures in the representation of semantic knowledge about 
verbs. The results of our study replicate these findings adding to the hypothesis that frontal 
lobe deficiencies influence the semantic impairment present in PD patients. On the other 
hand, PD patients in our study also presented a face naming deficit. Face processing has 
consistently been associated to the fusiform area, in the ventral region of the temporal lobe 
38-41, and has been suggested to be a useful predictor of dementia in prodromal and initial 
stages of Alzheimer disease 42. The results of our study suggest that assessment of face 
processing should also be conducted in the PD population in order to fully understand their 
cognitive profile. 
Together with the results of previous studies, the experiment presented here points out 
the existence of a cognitive deficit in PD patients that affects anterior- to posterior-
dependent capacities. Although executive functions, attention and recall tasks appear to be 
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amongst the most sensitive tests to detect cognitive impairment in PD patients, also mainly 
semantic tasks, like action and face naming, as well as semantic fluency, seem to be good 
indicators of this condition. Since MCI is believed to be a precursor of dementia6, and given 
that different profiles of impairment have been suggested to predict different varieties 43, a 
wide range of tasks should be applied to these patients in order to fully understand their 
cognitive deficit. 
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Table Legends: 
Table 1. Summary of participants’ characteristics. 
Table 2. Summary of scores of the two groups in the experimental tasks and results of 
the different analyses. 
 
 
